Vis enkel innførsel

dc.contributor.authorDenti, Vanna
dc.contributor.authorAndersen, Maria Karoline
dc.contributor.authorSmith, Andrew
dc.contributor.authorBofin, Anna M.
dc.contributor.authorNordborg, Anna
dc.contributor.authorMagni, Fulvio
dc.contributor.authorMoestue, Siver Andreas
dc.contributor.authorGiampà, Marco
dc.date.accessioned2022-03-04T09:10:28Z
dc.date.available2022-03-04T09:10:28Z
dc.date.created2021-08-24T07:23:28Z
dc.date.issued2021
dc.identifier.citationMetabolites. 2021, 11 (9), .en_US
dc.identifier.issn2218-1989
dc.identifier.urihttps://hdl.handle.net/11250/2983018
dc.description.abstractThe association between lipid metabolism and long-term outcomes is relevant for tumor diagnosis and therapy. Archival material such as formalin-fixed and paraffin embedded (FFPE) tissues is a highly valuable resource for this aim as it is linked to long-term clinical follow-up. Therefore, there is a need to develop robust methodologies able to detect lipids in FFPE material and correlate them with clinical outcomes. In this work, lipidic alterations were investigated in patient-derived xenograft of breast cancer by using a matrix-assisted laser desorption ionization mass spectrometry (MALDI MSI) based workflow that included antigen retrieval as a sample preparation step. We evaluated technical reproducibility, spatial metabolic differentiation within tissue compartments, and treatment response induced by a glutaminase inhibitor (CB-839). This protocol shows a good inter-day robustness (CV = 26 ± 12%). Several lipids could reliably distinguish necrotic and tumor regions across the technical replicates. Moreover, this protocol identified distinct alterations in the tissue lipidome of xenograft treated with glutaminase inhibitors. In conclusion, lipidic alterations in FFPE tissue of breast cancer xenograft observed in this study are a step-forward to a robust and reproducible MALDI-MSI based workflow for pre-clinical and clinical applications.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleReproducible lipid alterations in patient-derived breast cancer xenograft FFPE tissue identified with MALDI MSI for pre-clinical and clinical applicationen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber15en_US
dc.source.volume11en_US
dc.source.journalMetabolitesen_US
dc.source.issue9en_US
dc.identifier.doi10.3390/metabo11090577
dc.identifier.cristin1928187
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal